Victory Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-97
Closed -$3K – 2931
2020
Q1
$3K Buy
+97
New +$3.76K ﹤0.01% 3414
2019
Q4
– Sell
-109
Closed -$4K – 2986
2019
Q3
$4K Hold
109
– – ﹤0.01% 3509

Other funds holding LSTA

Victory Capital Management's LSTA Position: Q2 2020 in Review

Victory Capital Management sold out of Lisata Therapeutics (LSTA) in Q2 2020, closing a stake of 97 shares — an estimated $3K sold.

Victory Capital Management first reported a position in LSTA in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2019. 24 funds tracked by Wall St. Rank hold LSTA as of Q2 2020.

  • Victory Capital Management reported no remaining Lisata Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 97 Lisata Therapeutics shares in Q2 2020, an estimated $3K.
  • Victory Capital Management first reported a position in Lisata Therapeutics in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Lisata Therapeutics position peaked at $4K in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.